Crossref
CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability
European Journal of Cancer · 2026-11 · 248 · 118158
DOI: 10.1016/j.ejca.2026.118158 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Matvere.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Matvere, A. (2026). CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability. European Journal of Cancer, 248, 118158. https://doi.org/10.1016/j.ejca.2026.118158
Vancouver
Matvere A. CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability. European Journal of Cancer. 2026;248:118158. doi:10.1016/j.ejca.2026.118158
BibTeX
@article{Matvere2026,
author = {Matvere, A.},
title = {CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {118158},
doi = {10.1016/j.ejca.2026.118158}
}
EUVIMED